http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011203535-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f209ef5eb0bf426bf7278483ca9befc4 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2011-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b88843c5d888e408dfd0a09d541248e5 |
| publicationDate | 2011-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2011203535-A1 |
| titleOfInvention | Survivin peptide vaccine |
| abstract | tI'Ud4AUUl Abstract The present invention relates to a therapeutic vaccine comprising one or more survivin 5 polypeptide fragments. The vaccine can be used for prophylactic, ameliorating and/or curative treatment of e.g. cancer diseases. The invention further relates to methods of combination treatment. Fig. 3 < CD-~ z0 C) C C) ) C) C)F CD CD C) ) C) D C: C. L YC SBOP .~jjqvN |
| priorityDate | 2005-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 711.